Replication-competent bacterial artificial chromosomes of Marek's disease virus: Novel tools for generation of molecularly defined herpesvirus vaccines

Journal of Virology

Volumn 77, Issue 16, 2003, Pages 8712-8718

  Petherbridge, Lawrence ^a   Howes, Ken ^a   Baigent, Susan J ^a   Sacco, Melanie A ^a   Evans, Simon ^a   Osterrieder, Nikolaus ^b,c   Nair, Venugopal ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b Department of Obstetrics Gynecology   (United States)

^c FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; HERPES VACCINE; VIRUS VACCINE;

ANIMAL EXPERIMENT; ARTICLE; AVIAN LYMPHOMATOSIS HERPETOVIRUS; BACTERIAL ARTIFICIAL CHROMOSOME; BIRD DISEASE; CHICKEN; CONTROLLED STUDY; FRAMESHIFT MUTATION; GENE; GENE STRUCTURE; GENE TARGETING; HERPES VIRUS; IMMUNOGENICITY; MEQ GENE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

AMINO ACID SEQUENCE; BASE SEQUENCE; CHROMOSOMES, ARTIFICIAL, BACTERIAL; DNA PRIMERS; HERPESVIRIDAE; MARDIVIRUS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; SEQUENCE HOMOLOGY, NUCLEIC ACID; VACCINES, DNA; VIRAL VACCINES; VIRUS REPLICATION;

EID: 0042709459     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.16.8712-8718.2003     Document Type: Article

References (26)

1. Brune, W., M. Messerle, and U. H. Koszinowski. 2000. Forward with BACs: new tools for herpesvirus genomics. Trends Genet. 16:254-259.
2. Chang, K. S., S. I. Lee., K. Ohashi, A. Ibrahim, and M. Onuma. 2002. The detection of the meq gene in chicken infected with Marek's disease virus serotype 1. J. Vet. Med. Sci. 64:413-417.
3. Cui, Z. Z., A. Qin., L. F. Lee, P. Wu, and H. J. Kung. 1999. Construction and characterisation of a H19 epitope point mutant of MDV CVI988/Rispens strain. Acta Virol. 43:169-173.
4. Davidson, I., R. Borenshtain, and Y. Weisman. 2002. Molecular identification of the Marek's disease virus vaccine strain CVI988 in vaccinated chickens. J. Vet. Med. 49:83-87.
5. Dorange, F., B. K. Tischer, J.-F. Vautherot, and N. Osterrieder. 2002. Characterisation of Marek's disease virus serotype 1 (MDV-1) deletion mutants that lack UL46 to UL49 genes: MDV-1 UL49, encoding VP22, is indispensable for virus growth. J. Virol. 76:1959-1970.
6. Fukuchi, K., A. Tanaka, L. W. Schierman, R. L. Witter, and M. Nonoyama. 1985. The structure of Marek's disease virus DNA: the presence of unique expansion of nonpathogenic viral DNA. Proc. Natl. Acad. Sci. USA 82:751-754.
7. Hooft van Iddekinge, B. J. L., L. Stenzler, K. A. Schat, H. Boerrigter, and G. Koch. 1999. Genome analysis of Marek's disease virus strain CVI-988: effect of cell culture passage on the inverted repeat regions. Avian Dis. 43:182-188.
8. Lee, S.-I., M. Takagi, K. Ohashi, C. Sugimoto, and M. Onuma. 2000. Difference in the meq gene between oncogenic and attenuated strains of Marek's disease virus serotype 1. J. Vet. Med. Sci. 62:287-292.
9. Qian, Z., P. Brunovskis, F. Rauscher III, L. F. Lee, and H.-J. Kung. 1995. Transactivation activity of Meq, a Marek's disease herpesvirus BZIP protein persistently expressed in latently infected transformed T cells. J. Virol. 69:4037-4044.
10. Qian, Z., P. Brunovskis, L. F. Lee, P. K. Vogt, and H.-J. Kung. 1996. Novel DNA binding specificities of a putative herpesvirus bZIP oncoprotein. J. Virol. 70:7161-7170.
11. Rispens, B. H., H. van Vloten, N. Mastenbroek, H. J. Mass, and K. A. Schat. 1972. Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI988) and its use in laboratory vaccination trials. Avian Dis. 16:108-125.
12. Ross, L. J. N. 1998. Recombinant vaccines against Marek's disease. Avian Pathol. 27:S65-S73.
13. Schat, K. A., B. W. Calnek, and J. Fabricant. 1982. Characterisation of two highly oncogenic strains of Marek's disease virus. Avian Pathol. 11:593-605.
14. Schumacher, D., B. K. Tischer, W. Fuchs, and N. Osterrieder. 2000. Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant. J. Virol. 74:11088-11098.
15. Schumacher, D., B. K. Tischer, J.-P. Teifke, K. Wink, and N. Osterrieder. 2002. Generation of a permanent cell line that supports efficient growth of Marek's disease virus (MDV) by constitutive expression of MDV glycoprotein E. J. Gen. Virol. 83:1987-1992.
16. Suter, M., A. M. Lew, P. Grob, G. J. Adema, M. Ackerman, K. Shortman, and C. Fraefel. 1999. BAC-VAC, a novel generation of DNA vaccines: a bacterial artificial chromosome (BAC) containing a replication-competent, packaging-defective virus genome induces protective immunity against herpes simplex virus 1. Proc. Natl. Acad. Sci. USA 96:12697-12702.
17. Smith, G. A., and L. W. Enquist. 2000. A self-recombining bacterial artificial chromosome and its application for analysis of herpesvirus pathogenesis. Proc. Natl. Acad. Sci. USA 97:4873-4878.
18. Tischer, B. K., D. Schumacher, M. Beer, J. Beyer, J. P. Teifke, K. Osterrieder, K. Wink, V. Zelnik, F. Fehler, and N. Osterrieder. 2002. The products of UL10 (gM) and the UL49.5 genes of Marek's disease virus serotype 1 are essential for virus growth in cultured cells. J. Gen. Virol. 83:997-1003.
19. Tischer, B. K., D. Schumacher, M. Beer, J. Beyer, J. P. Teifke, K. Osterrieder, K. Wink, V. Zelnik, F. Fehler, and N. Osterrieder. 2002. A DNA vaccine containing an infectious Marek's disease virus genome can confer protection against tumourigenic Marek's disease in chickens. J. Gen. Virol. 83:2367-2376.
20. van Regenmortel, M. H. V., C. M. Fauqet, D. H. L. Bishop, E. Carstens, M. K. Estes, S. Lemon, J. Maniloff, M. A. Mayo, D. McGeoch, C. R. Pringle, and R. B. Wickner. 2000. Virus taxonomy. Seventh report of the International Committee on Taxonomy of Viruses. Academic Press, San Diego, Calif.
21. Wagner, M., S. Jonjic, U. H. Koszinowski, and M. Messerle. 1999. Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J. Virol. 73:7056-7060.
22. Wagner, M., Z. Ruzsics, and U. H. Koszinowski. 2002. Herpesvirus genetics has come of age. Trends Microbiol. 10:318-324.
23. Witter, R. L. 1997. Increased virulence of Marek's disease virus field isolates. Avian Dis. 41:149-163.
24. Witter, R. L. 1992. Safety and comparative efficacy of the CVI988/Rispens vaccine strain, p. 315-319. In 4th International Symposium on Marek's disease, 19th World's Poultry Congress, vol. 1. World's Poultry Science Association, Amsterdam, The Netherlands.
25. Witter, R. L. 2001. Protective efficacy of Marek's disease vaccines. Curr. Top. Microbiol. Immunol. 255:57-90.
26. Witter, R. L. 2001. Marek's disease virus vaccines - past, present and future (chicken vs. virus - a battle of the centuries), p. 1-9. In K. A. Schat, R. M. Morgan, M. S. Parcells, and J. L. Spencer (ed.), Current progress on Marek's disease research. Proceedings of the 6th International Symposium on Marek's disease. American Association of Avian Pathologists, Kennett Square, Pa.